SCHEMBL6070167

SCHEMBL6070167

CN1CCN(C(=O)c2cc(Cl)cc(Nc3nccc(-c4ccnn4-c4ccccc4)n3)c2)CC1

nearest known ligand 0.51

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
SYK P43405 18/20 0.51
CDK1 P06493 1/20 0.49
CDK2 P24941 1/20 0.49
JAK2 O60674 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6070502 0.91 CAMK2D (0.46) SYK
SCHEMBL6070706 0.91 CDK1 (0.51) SYKCDK1CDK2
SCHEMBL6069652 0.88 CDK2 (0.62) SYKCDK1CDK2JAK2
SCHEMBL6070820 0.83 SYK (0.44) SYKCDK2JAK2
SCHEMBL6070028 0.82 SYK (0.46) SYKCDK1CDK2
SCHEMBL6069930 0.79 KDR (0.52) SYKCDK1CDK2JAK2
SCHEMBL6070287 0.78 KDR (0.44) SYKJAK2
SCHEMBL6070034 0.78 MKNK1 (0.55) SYKCDK1CDK2
SCHEMBL6071031 0.78 KDR (0.43) SYKJAK2
SCHEMBL6069976 0.77 CDK2 (0.59) CDK1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7109204-B2 controlling signal transduction; anticancer agents, antitumor agents, atherosclerosis, vision defects, antidiabetic agents, antiinflammatory agents MERCK & CO., INC. (US) 2006-09-19 US disclosed